Ocumension Therapeutics Launches Initial Public Offering on Hong Kong Stock Exchange
- Friday, July 10, 2020, 7:11
- Business
- Add a comment
SHANGHAI, July 10, 2020 /PRNewswire/ — Ocumension Therapeutics (“Ocumension”), a China-based ophthalmic pharmaceutical platform company, has today launched its Initial Public Offering (IPO) of the company’s stock on The Stock Exchange of Hong Kong (HKEX). Ocumension plans to offer…
About the Author
adminasapcorp has written 41771 stories on this site.